Donald K. Hamlin

2.9k total citations
102 papers, 2.2k citations indexed

About

Donald K. Hamlin is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Donald K. Hamlin has authored 102 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 87 papers in Radiology, Nuclear Medicine and Imaging, 19 papers in Oncology and 17 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Donald K. Hamlin's work include Radiopharmaceutical Chemistry and Applications (78 papers), Monoclonal and Polyclonal Antibodies Research (30 papers) and Medical Imaging Techniques and Applications (22 papers). Donald K. Hamlin is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (78 papers), Monoclonal and Polyclonal Antibodies Research (30 papers) and Medical Imaging Techniques and Applications (22 papers). Donald K. Hamlin collaborates with scholars based in United States, South Africa and Canada. Donald K. Hamlin's co-authors include D. Scott Wilbur, Ming‐Kuan Chyan, Robert L. Vessella, Pradip M. Pathare, Oliver W. Press, Brenda M. Sandmaier, John M. Pagel, Erlinda B. Santos, Darrell R. Fisher and Ajay K. Gopal and has published in prestigious journals such as Blood, PLoS ONE and Cancer Research.

In The Last Decade

Donald K. Hamlin

100 papers receiving 2.1k citations

Peers

Donald K. Hamlin

RNMI

PRM

ONCOL

Alain Faivre-Chauvet France

D. Scott Wilbur United States

Hazel B. Breitz United States

Franz Buchegger Switzerland

Jean‐François Chatal France

Dangshe Ma United States

RB Pedley United Kingdom

Marco Chinol Italy

Johannes Notni Germany

Yukang Lin United States

Alain Faivre-Chauvet France

Donald K. Hamlin

1.7k ×1.1

RNMI

421 ×1.0

429 ×1.0

PRM

720 ×1.9

ONCOL

179 ×0.7

Citations per year, relative to Donald K. Hamlin Donald K. Hamlin (= 1×) peers Alain Faivre-Chauvet

Countries citing papers authored by Donald K. Hamlin

Since Specialization

Citations

This map shows the geographic impact of Donald K. Hamlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald K. Hamlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald K. Hamlin more than expected).

Fields of papers citing papers by Donald K. Hamlin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donald K. Hamlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald K. Hamlin. The network helps show where Donald K. Hamlin may publish in the future.

Co-authorship network of co-authors of Donald K. Hamlin

This figure shows the co-authorship network connecting the top 25 collaborators of Donald K. Hamlin. A scholar is included among the top collaborators of Donald K. Hamlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donald K. Hamlin. Donald K. Hamlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Radtke, Stefan, George S. Laszlo, Nicholas Petty, et al.. (2024). CD45-Directed Radioimmunotherapy with the Alpha-Emitter Astatine-211 As Conditioning for Autologous Hematopoietic Stem/Progenitor Cell Gene Therapy: Results from a Nonhuman Primate Model. Blood. 144(Supplement 1). 2014–2014.

Hamlin, Donald K., Kevin P. Labadie, Yong-Jun Liu, et al.. (2024). Pilot study of humanized glypican-3-targeted zirconium-89 immuno-positron emission tomography for hepatocellular carcinoma. EJNMMI Research. 14(1). 74–74. 2 indexed citations

Laszlo, George S., Brenda M. Sandmaier, Johnnie J. Orozco, et al.. (2023). [ ²¹¹ At]astatine-based anti-CD22 radioimmunotherapy for B-cell malignancies. Leukemia & lymphoma. 64(7). 1335–1339. 2 indexed citations

Laszlo, George S., Johnnie J. Orozco, Donald K. Hamlin, et al.. (2022). Development of [211At]astatine-based anti-CD123 radioimmunotherapy for acute leukemias and other CD123+ malignancies. Leukemia. 36(6). 1485–1491. 15 indexed citations

Labadie, Kevin P., Donald K. Hamlin, Aimee L. Kenoyer, et al.. (2021). Glypican-3–Targeted ²²⁷Th α-Therapy Reduces Tumor Burden in an Orthotopic Xenograft Murine Model of Hepatocellular Carcinoma. Journal of Nuclear Medicine. 63(7). 1033–1038. 20 indexed citations

Orozco, Johnnie J., Aimee L. Kenoyer, Yukang Lin, et al.. (2020). Therapy of Myeloid Leukemia using Novel Bispecific Fusion Proteins Targeting CD45 and 90Y-DOTA. Molecular Cancer Therapeutics. 19(12). 2575–2584. 8 indexed citations

Woen, David H., Nickolas H. Anderson, Eva R. Birnbaum, et al.. (2020). A Solid-State Support for Separating Astatine-211 from Bismuth. Inorganic Chemistry. 59(9). 6137–6146. 16 indexed citations

Li, Yawen, Ming‐Kuan Chyan, Donald K. Hamlin, et al.. (2020). Evaluation of radioiodinated protein conjugates and their potential metabolites containing lysine-urea-glutamate (LuG), PEG and closo-decaborate(2-) as models for targeting astatine-211 to metastatic prostate cancer.. Nuclear Medicine and Biology. 92. 217–227. 10 indexed citations

O’Hara, Matthew J., et al.. (2019). Development of an autonomous solvent extraction system to isolate astatine-211 from dissolved cyclotron bombarded bismuth targets. Scientific Reports. 9(1). 20318–20318. 11 indexed citations

10.

O’Steen, Shyril, Damian J. Green, Ajay K. Gopal, et al.. (2017). Venetoclax Synergizes with Radiotherapy for Treatment of B-cell Lymphomas. Cancer Research. 77(14). 3885–3893. 23 indexed citations

11.

Green, Damian J., Shani L. Frayo, Yukang Lin, et al.. (2016). Comparative Analysis of Bispecific Antibody and Streptavidin-Targeted Radioimmunotherapy for B-cell Cancers. Cancer Research. 76(22). 6669–6679. 22 indexed citations

12.

Burtner, Christopher R., Erlinda B. Santos, Brian C. Beard, et al.. (2015). ²¹¹ Astatine-Conjugated Monoclonal CD45 Antibody-Based Nonmyeloablative Conditioning for Stem Cell Gene Therapy. Human Gene Therapy. 26(6). 399–406. 13 indexed citations

13.

Green, Damian J., Nural Orgun, Jon C. Jones, et al.. (2013). A Preclinical Model of CD38-Pretargeted Radioimmunotherapy for Plasma Cell Malignancies. Cancer Research. 74(4). 1179–1189. 40 indexed citations

14.

Orozco, Johnnie J., Tom Bäck, Aimee L. Kenoyer, et al.. (2013). Anti-CD45 radioimmunotherapy using 211At with bone marrow transplantation prolongs survival in a disseminated murine leukemia model. Blood. 121(18). 3759–3767. 54 indexed citations

15.

Wilbur, D. Scott, Ming‐Kuan Chyan, Hirohisa Nakamae, et al.. (2012). Reagents for Astatination of Biomolecules. 6. An Intact Antibody Conjugated with a Maleimido-closo-Decaborate(2-) Reagent via Sulfhydryl Groups Had Considerably Higher Kidney Concentrations than the Same Antibody Conjugated with an Isothiocyanato-closo-Decaborate(2-) Reagent via Lysine Amines. Bioconjugate Chemistry. 23(3). 409–420. 59 indexed citations

16.

Park, Steven, Donald K. Hamlin, Yukang Lin, et al.. (2011). Pretargeted Radioimmunotherapy Using Genetically Engineered Antibody-Streptavidin Fusion Proteins for Treatment of Non-Hodgkin Lymphoma. Clinical Cancer Research. 17(23). 7373–7382. 27 indexed citations

17.

Nakamae, Hirohisa, D. Scott Wilbur, Donald K. Hamlin, et al.. (2009). Biodistributions, Myelosuppression, and Toxicities in Mice Treated with an Anti-CD45 Antibody Labeled with the α-Emitting Radionuclides Bismuth-213 or Astatine-211. Cancer Research. 69(6). 2408–2415. 43 indexed citations

18.

Wilbur, D. Scott, Donald K. Hamlin, Rajiv Ranjan Srivastava, & Ming‐Kuan Chyan. (2004). Synthesis, radioiodination, and biodistribution of some nido- and closo-monocarbon carborane derivatives. Nuclear Medicine and Biology. 31(4). 523–530. 27 indexed citations

19.

Sosabowski, Jane, Jamal Zweit, Helen M. Coley, et al.. (1998). Preparation and evaluation of N-acylated anthracycline analogues for radiolabelling with I-124 and Br-76 - potential radiotracers for in vivo assessment of multidrug resistance. Journal of Labelled Compounds and Radiopharmaceuticals. 37. 111–113. 1 indexed citations

20.

Wilbur, D. Scott, Donald K. Hamlin, Rajiv Ranjan Srivastava, & H. Donald Burns. (1993). Synthesis and radioiodination of N-Boc-p-(tri-n-butylstannyl)-L-phenylalanine tetrafluorophenyl ester: Preparation of a radiolabeled phenylalanine derivative for peptide synthesis. Bioconjugate Chemistry. 4(6). 574–580. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact